Innate immunity and toll-like receptor antagonists: A potential role in the treatment of cardiovascular diseases

Cardiovascular Therapeutics

Volumn 27, Issue 2, 2009, Pages 117-123

  Lin, Elaine ^a   Freedman, Jane E ^a   Beaulieu, Lea M ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Atherosclerosis; Cardiovascular disease; Myocardial Ischemic reperfusion injury; Thrombosis; TLR antagonist; TLRs; Valvular disease

Indexed keywords

6 [N (2 CHLORO 4 FLUOROPHENYL)SULFAMOYL] 1 CYCLOHEXENE 1 CARBOXYLIC ACID ETHYL ESTER; ANGIOTENSIN RECEPTOR ANTAGONIST; ERITORAN; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOLOGIC AGENT; PLACEBO; SIMVASTATIN; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ALLERGY; ANTIINFLAMMATORY ACTIVITY; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; DRUG MEGADOSE; DRUG TARGETING; HEART MUSCLE ISCHEMIA; HUMAN; HYPERLIPIDEMIA; INFECTION; INNATE IMMUNITY; ISCHEMIA; NEOPLASM; NONHUMAN; PATHOGENESIS; PHLEBITIS; PRIORITY JOURNAL; REPERFUSION INJURY; REVIEW; RHEUMATOID ARTHRITIS; SEPSIS; THROMBOGENESIS; THROMBOSIS; VALVULAR HEART DISEASE;

ANIMALS; ANTI-INFLAMMATORY AGENTS; CARDIOVASCULAR AGENTS; CARDIOVASCULAR DISEASES; HUMANS; IMMUNITY, INNATE; TOLL-LIKE RECEPTORS;

EID: 65549092335     PISSN: 17555914     EISSN: 17555922     Source Type: Journal    
DOI: 10.1111/j.1755-5922.2009.00077.x     Document Type: Review

References (44)

1. Matzinger P. The danger model: A renewed sense of self. Science 2002 296 : 301 305. (Pubitemid 34303674)
2. Mollen KP, Anand RJ, Tsung A, Prince JM, Levy RM, Billiar TR. Emerging paradigm: Toll-like receptor 4 - sentinel for the detection of tissue damage. Shock 2006 26 : 430 437. (Pubitemid 44632271)
3. Frantz S, Ertl G, Bauersachs J. Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007 4 : 444 454. (Pubitemid 47180328)
4. Mullick AE, Soldau K, Kiosses WB, Bell TA III., Tobias PS, Curtiss LK. Increased endothelial expression of toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events. J Exp Med 2008 205 : 373 383.
5. Liu X, Ukai T, Yumoto H, Davey M, Goswami S, Gibson FC III. Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis 2008 196 : 146 154.
6. Ishikawa Y, Satoh M, Itoh T, Minami Y, Takahashi Y, Akamura M. Local expression of toll-like receptor 4 at the site of ruptured plaques in patients with acute myocardial infarction. Clin Sci 2008 115 : 133 140.
7. Xu XH, Shah PK, Faure E, Equils O, Thomas L, Fishbein MC. Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL. Circulation 2001 104 : 3103 3108. (Pubitemid 34014065)
8. Schoneveld AH, Hoefer I, Sluijter JP, Laman JD, de Kleijn DP, Pasterkamp G. Atheroscerotic lesion development and Toll-like receptor 2 and 4. Atherosclerosis 2008 197 : 95 104.
9. Otsui K, Inoue N, Kobayashi S, Shiraki R, Honjo T, Takahashi M. Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 2007 22 : 416 422. (Pubitemid 350201439)
10. Loppnow H, Werdan K, Buerke M. Vascular cells contribute to atherosclerosis by cytokine and innate-immunity-related inflammatory mechanisms. Innate Immun 2008 14 : 63 87.
11. Niessner A, Shin MS, Pryshchep O, Goronzy JJ, Chaikof EL, Weyand CM. Synergistic proinflammatory effects of the antiviral cytokine interferon-alpha and toll-like receptor 4 ligands in the atherosclerotic plaque. Circulation 2007 116 : 2043 2052. (Pubitemid 350023750)
12. Gibson FC, Ukai T, Genco CA. Engagement of specific innate immune signaling pathways during Porphyromonas gingivalis induced chronic inflammation and atherosclerosis. Front Biosci 2008 13 : 2041 2059.
13. Shinohara M, Hirata K, Yamashita T, Takaya T, Sasaki N, Shiraki R. Local expression of toll-like receptors at the vessel wall induces atherosclerotic lesion formation: Synergism of TLR2 and TLR4. Arterioscler Thromb Vasc Biol 2007 27 : 2384 2391. (Pubitemid 350203954)
14. Mizoguchi E, Orihara K, Hamasaki S, Ishida S, Kataoka T, Ogawa M. Association between toll-like receptors and the extent and severity of coronary artery disease in patients with stable angina. Coron Artery Dis 2007 17 : 31 38.
15. Shiraki R, Inoue N, Kawasaki S, Takei A, Kadotani M, Ohnishi Y. Expression of toll-like receptors on human platelets. Thromb Res 2004 113 : 379 385. (Pubitemid 38844368)
16. Cognasse F, Hamzeh H, Chavarin P, Acquart S, Genin C, Garraud O. Evidence of toll-like receptor molecules on human platelets. Immunol Cell Biol 2005 83 : 196 198. (Pubitemid 40469328)
17. Andonegui G, Kerfoot SM, McNagny K, Ebbert KV, Patel KD, Kubes P. Platelets express functional toll-like receptor-4. Blood 2005 106 : 2417 2423. (Pubitemid 41510815)
18. Montrucchio G, Bosco O, Del Sorbo L, Fascio Pecetto P, Lupia E, Goffi A. Mechanisms of the priming effect of low doses of lipopolysaccharides on leukocyte-dependent platelet aggregation in whole blood. Thromb Haemost 2003 90 : 872 881. (Pubitemid 37427857)
19. Blair PS, Rex S, Vitseva O, Beaulieu L, Tanriverdi K, Chakrabarti S. Stimulation of toll-like receptor 2 in human platelets induces a thrombo-inflammatory response through activation of phosphoinositide 3-kinase. Circ Res 2009 104 : 346 354.
20. Smeeth L, Thomas SL, Hall AJ, Hubbard R, Farrington P, Vallance P. Risk of myocardial infarction and stroke after acute infection or vaccination. N Engl J Med 2004 351 : 2611 2618. (Pubitemid 39628582)
21. Jayachandran M, Brunn GJ, Karnicki K, Miller RS, Owen WG, Miller VM. In vivo effects of lipopolysaccharide and TLR4 on platelet production and activity: Implications for thrombotic risk. J Appl Physiol 2007 102 : 429 433. (Pubitemid 46089795)
22. Frantz S, Kobzik L, Kim YD, Fukazawa R, Medzhitov R, Lee RT. TLR4 expression in cardiac myocytes in normal and failing myocardium. J Clin Invest 1999 104 : 271 280.
23. Boyd JH, Mathur S, Wang Y, Bateman RM, Walley KR. Toll-like receptor stimulation in cardiomyocytes decreases contractility and initiates an NF-κB dependent inflammatory response. Cardiovasc Res 2006 72 : 384 393. (Pubitemid 44665856)
24. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ. Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 2008 102 : 257 264.
25. Riad A, Jäger S, Sobirey M, Escher F, Yaulema-Riss A, Westermann D. Toll-like receptor-4 modulates survival by induction of left ventricular remodeling after myocardial infarction in mice. J Immunol 2008 180 : 6954 6961.
26. Sheu JJ, Chang LT, Chiang CH, Youssef AA, Wu CJ, Lee FY. Prognostic value of activated toll-like receptor-4 in monocytes following acute myocardial infarction. Int Heart J 2008 49 : 1 11.
27. Knuefermann P, Schwederski M, Velten M, Krings P, Ehrentraut H, Rüdiger M. Bacterial DNA induces myocardial inflammation and reduces cardiomyocyte contractility: Role of toll-like receptor 9. Cardiovasc Res 2008 78 : 26 35.
28. Shimamoto A, Chong AJ, Yada M, Shomura S, Takayama H, Fleisig AJ. Inhibition of toll-like receptor 4 with eritoran attenuates myocardial ischemia-reperfusion injury. Circulation 2006 114 : 270 274. (Pubitemid 44297162)
29. Oyama J, Blais C Jr., Liu X, Pu M, Kobzik L, Kelly RA. Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice. Circulation 2004 109 : 784 789. (Pubitemid 38222900)
30. Zou N, Ao L, Cleveland JC Jr., Yang X, Su X, Cai GY. Critical role of extracellular heat shock cognate protein 70 in the myocardial inflammatory response and cardiac dysfunction after global ischemia-reperfusion. Am J Physiol Heart Circ Physiol 2008 294 : 2805 2813.
31. Favre J, Musette P, Douin-Echinard V, Laude K, Henry JP, Arnal JF. Toll-like receptors 2-deficient mice are protected against post-ischemic coronary dysfunction. Arterioscler Thromb Vasc Biol 2007 27 : 1064 1071. (Pubitemid 46641958)
32. Meng X, Ao L, Song Y, Babu A, Yang X, Wang M. Expression of functional toll-like receptors 2 and 4 in human aortic valve interstitial cells: Potential roles in aortic valve inflammation and stenosis. Am J Physiol Cell Physiol 2008 294 : 29 35.
33. Babu AN, Meng X, Zou N, Yang X, Wang M, Song Y. Lipopolysaccharide stimulation of human aortic valve interstitial cells activates inflammation and osteogenesis. Ann Thorac Surg 2008 86 : 71 76.
34. Toli K, Paraskevas KI, Poulakou MV, Agrogiannis G, Kavantzas N, Xanthopoulos V. Association between plasma levels and immunolocalization of cytokines in heart valve lesions: A possible target for treatment? Expert Opin Ther Targets 2008 12 : 1209 1215.
35. Hodgkinson CP, Ye S. Statins inhibit toll-like receptor-mediated lipopolysaccharide signaling and cytokine expression. Pharmacogenet Genomics 2008 18 : 803 813.
36. Földes G, von Haehling S, Okonko DO, Jankowska EA, Poole-Wilson PA, Anker SD. Fluvastatin reduces increased blood monocyte toll-like receptor 4 expression in whole blood from patients with chronic heart failure. Int J Cardiol 2008 124 : 80 85.
37. Yasuda T, Hirata K, Ishida T, Kojima Y, Tanaka H, Okada T. Endothelial lipase is increased by inflammation and promotes LDL uptake in macrophages. J Atheroscler Thromb 2007 14 : 192 201.
38. 1 receptor blockade decreases lipopolysaccharide- induced inflammation in the rat adrenal gland. Endocrinology 2008 149 : 5177 5188.
39. Dasu MR, Riosvelasco AC, Jialal I. Candesartan inhibits toll-like receptor expression and activity both in vitro and in vivo. Atherosclerosis 2009 202 : 76 83.
40. Zhang Y, Gaekwad J, Wolfert MA, Boons GJ. Synthetic tetra-acylated derivatives of lipid A from Porphyromonas gingivalis are antagonists of human TLR4. Org Biomol Chem 2008 6 : 3371 3381.
41. LeBouder E, Rey-Nores JE, Rushmere NK, Grigorov M, Lawn SD, Affolter M. Soluble forms of toll-like receptor 2 capable of modulating TLR2 signaling are present in human plasma and breast milk. J Immunol 2003 171 : 6680 6689. (Pubitemid 37532100)
42. Ueland T, Espevik T, Kjekshus J, Gullestad L, Omland T, Squire IB. Mannose binding lectin fand soluble toll-like receptor 2 in heart failure following acute myocardial infarction. J Card Fail 2006 12 : 659 663. (Pubitemid 44540257)
43. Blanco AM, Vallés SL, Pascual M, Guerri C. Involvement of TLR4/type I IL-1 receptor signaling in the induction of inflammatory mediators and cell death induced by ethanol in cultured astrocytes. J Immunol 2005 175 : 6893 6899. (Pubitemid 41599911)
44. Wickelgren I. Targeting the tolls. Science 2006 312 : 184 187.